Calumet Specialty Products
CLMT
91 hedge funds and large institutions have $558M invested in Calumet Specialty Products in 2024 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 17 closing their positions.
141% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 17
137% more call options, than puts
Call options by funds: $80.1M | Put options by funds: $33.8M
46% more capital invested
Capital invested by funds: $383M → $558M (+$175M)
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
32% more funds holding
Funds holding: 69 → 91 (+22)
6.92% more ownership
Funds ownership: 29.64% → 36.56% (+6.9%)
5% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$62.5M |
| 2 |
BlackRock
New York
|
+$17.7M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.7M |
| 4 |
TCM
Tyro Capital Management
Miami,
Florida
|
+$11.4M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$9.86M |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$9.18M |
| 3 |
Corient Private Wealth
Miami,
Florida
|
-$7.44M |
| 4 |
Morgan Stanley
New York
|
-$3.11M |
| 5 |
GC
Grizzlyrock Capital
Chicago,
Illinois
|
-$2.65M |
CLMT Hedge Fund Activity: Q3 2024 in Review
91 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q3 2024, worth a combined $558M — up 46% from $383M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new CLMT positions and 17 closed out — a net gain of 24 holders — while 18 added to existing stakes and 19 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $62.5M. The largest seller was Goldman Sachs, cutting an estimated $9.86M.
- 91 institutional investors held Calumet Specialty Products (CLMT) as of Q3 2024, up from 69 in Q2 2024.
- Funds reported $558M of Calumet Specialty Products stock for Q3 2024, up 46% quarter-over-quarter.
- 41 funds opened new Calumet Specialty Products positions in Q3 2024 and 17 closed out, a net change of +24 holders.
- The largest Calumet Specialty Products buyer in Q3 2024 was Vanguard Group, an estimated $62.5M added.
- The largest Calumet Specialty Products seller in Q3 2024 was Goldman Sachs, an estimated $9.86M sold.
Based on aggregated 13F filings for Q3 2024.